Network pharmacology combined with molecular docking revealed the potential targets of Coridius chinensis in prostate cancer treatment

Figure 1 A schematic diagram of the study on Coridius chinensis as an anti-prostate cancer treatment. Network pharmacology was used to filter the compounds of Coridius chinensis for the treatment of prostate cancer; after 63 molecular docking studies, four bioactive compounds were found to bind tightly with candidate molecules.